Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Adoptive T‐Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy
Ist Teil von
American journal of transplantation, 2009-07, Vol.9 (7), p.1679-1684
Ort / Verlag
Malden, USA: Blackwell Publishing Inc
Erscheinungsjahr
2009
Quelle
Wiley Online Library All Journals
Beschreibungen/Notizen
Infections with cytomegalovirus (CMV) can induce severe complications after transplantation, particularly in patients resistant to virostatic therapy. Adoptive transfer of CMV‐specific T‐cell lines has demonstrated promising results in patients after hematopoietic stem cell transplantation. However, the generation of specific T‐cell lines ex vivo and their function in vivo is complicated in solid organ transplant (SOT) recipients. Here, we present the successful adoptive transfer of autologous CMV‐specific T cells to a lung transplant recipient with ganciclovir‐resistant CMV‐pneumonia requiring mechanical ventilation. Infused T cells rapidly expanded in vivo and efficiently inhibited viral replication as confirmed by extensive longitudinal immunological monitoring. After full recovery, the patient was released from the clinic. After 4 weeks, the infection reappeared and persisted at a low level even after a second T‐cell infusion. Our experimental data indicate that this could be the consequence of the late differentiated phenotype of the infused T cells and therefore their insufficient longevity in vivo. In summary, our report signifies the high therapeutic potential of adoptive immunotherapy in the treatment of SOT recipients when all other measures show no effect. Further studies have to elucidate the most potent strategies to generate antigen‐specific T cells with high functional capacity and robust long‐term persistence.
The adoptive transfer of specific T‐cell lines was examined as a new treatment strategy for SOT recipients suffering from severe CMV infections with resistance to antiviral.